Tanvex Biopharma's total assets for Q4 2022 were $3.42B, a decrease of ― from the previous quarter. TANVF total liabilities were $2.03B for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.